Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome

Figure 1

Sensitivity and specificity parameters for serum endocan, HSI, and FLI in patients of NAFLD. HSI: hepatic steatosis index; FLI: fatty liver index; NAFLD: nonalcoholic fatty liver disease.